Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice

Area of Science:

• Genomic Medicine
• Clinical Genetics
• Bioethics

Background:

• Clinical genomic sequencing is expanding rapidly, leading to more incidental findings.
• Best practices for managing and disclosing secondary findings are still evolving.
• Ethical considerations and patient autonomy are central to genomic data interpretation.

Approach:

• The North Carolina Clinical Genomic Evaluation by Next Generation Exome Sequencing (NCGENES) project is used as a case study.
• Analysis of different consent models for genomic sequencing.
• Examination of the impact of consent on patient decision-making regarding secondary findings.

Key Points:

• Controversies exist regarding the identification and disclosure of incidental findings in genomic sequencing.
• Empirical data is needed to guide best practices in returning secondary findings.
• Consent models significantly influence how patients approach incidental genomic information.

Conclusions:

• The management of secondary findings requires careful consideration of ethical, legal, and social implications.
• Informed consent processes must adapt to the complexities of clinical genomics.
• Further research is essential to establish clear guidelines for genetic counseling practice.